Observational Evidence for GLP-1RAs Real-world data in ARDs, particularly rheumatoid arthritis and systemic lupus erythematosus, suggest GLP-1RA use is associated with lower rates of major adverse cardiovascular events and all-cause mortality, mirroring findings in broader populations
A comprehensive flowchart of the data selection, refinement, and utilization process is provided in Fig
TsaoCWAdayAWAlmarzooqZIAndersonCAMAroraPAveryCLet alHeart disease and stroke statistics 2023 update: a report from the American Heart Association
Dermatology General Physician Healthcare practitioner Disclaimer: To be used strictly under the guidance of a qualified healthcare professional
It also means allergic reactions are unlikely, though not impossible, since any foreign substance can theoretically trigger sensitivity in susceptible individuals
Regulatory bodies like the FDA have a rigorous, multi-phase process for approving new drugs that can take over a decade and cost billions of dollars